SYNTHESIS AND HISTAMINE H-2 AGONISTIC ACTIVITY OF ARPROMIDINE ANALOGS - REPLACEMENT OF THE PHENIRAMINE-LIKE MOIETY BY NONHETEROCYCLIC GROUPS

被引:28
作者
BUSCHAUER, A [1 ]
FRIESEKIMMEL, A [1 ]
BAUMANN, G [1 ]
SCHUNACK, W [1 ]
机构
[1] TECH UNIV MUNICH, DEPT MED 1, DIV CARDIOL & CIRCULAT, W-8000 MUNICH 80, GERMANY
关键词
HISTAMINE; H-2; RECEPTOR; AGONIST; ARPROMIDINE; IMPROMIDINE; H-1; ANTAGONIST; ANTIHISTAMINE;
D O I
10.1016/0223-5234(92)90145-Q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Analogues of the potent histamine H-2 agonist arpromidine, characterized by non-heterocyclic groups (phenyl, cyclo-hexyl, alkyl) instead of the pheniramine-like portion, were prepared and tested for their H-2 agonistic and H-1 antagonistic activity in the isolated guinea pig right atrium and ileum, respectively. In the diphenylpropylguanidine series an increase in H-2 agonistic potency resulted from mono- or difluorination at one or both phenyl rings in the meta and/or para position (pD2 less-than-or-equal-to 7.75 vs pD2 = 7.15 for the unsubstituted parent compound). Compounds chlorinated at both phenyl rings were considerably less potent. Highest combined H-2 agonistic/H-1 antagonistic potency was found in the 4-fluorophenyl series. The arpromidine analogue with cyclohexyl and methyl group instead of phenyl and pyridine ring proved to be 30 times more potent than histamine in the atrium. The H-1 antagonistic potency in cyclohexyl compounds was lower than in the diaryl series. Thus, aromatic rings appear not to be required for high H-2 agonistic potency but are useful for combined H-2 agonistic/H-1 antagonistic activity.
引用
收藏
页码:321 / 330
页数:10
相关论文
共 44 条
[1]   SUBSTITUTED 1,2,3,4-TETRAHYDROAMINONAPHTHOLS - ANTIHYPERTENSIVE AGENTS, CALCIUM-CHANNEL BLOCKERS, AND ADRENERGIC-RECEPTOR BLOCKERS WITH CATECHOLAMINE-DEPLETING EFFECTS [J].
ATWAL, KS ;
OREILLY, BC ;
RUBY, EP ;
TURK, CF ;
ABERG, G ;
ASAAD, MM ;
BERGEY, JL ;
MORELAND, S ;
POWELL, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (04) :627-635
[2]  
BAUMANN G, 1988, INN MED, V15, P30
[3]   POSSIBLE VALUE OF H-2-RECEPTOR AGONISTS FOR TREATMENT OF CATECHOLAMINE-INSENSITIVE CONGESTIVE HEART-FAILURE [J].
BAUMANN, G ;
PERMANETTER, B ;
WIRTZFELD, A .
PHARMACOLOGY & THERAPEUTICS, 1984, 24 (02) :165-177
[4]   APPARENT SUPERIORITY OF H-2-RECEPTOR STIMULATION AND SIMULTANEOUS BETA-BLOCKADE OVER CONVENTIONAL TREATMENT WITH BETA-SYMPATHOMIMETIC DRUGS IN POST-ACUTE MYOCARDIAL-INFARCTION - CARDIAC EFFECTS OF IMPROMIDINE - A NEW SPECIFIC H-2-RECEPTOR AGONIST - IN THE SURVIVING CATECHOLAMINE-INSENSITIVE MYOCARDIUMIC [J].
BAUMANN, G ;
FELIX, SB ;
HEIDECKE, CD ;
RIESS, G ;
LOHER, U ;
LUDWIG, L ;
BLOMER, H .
AGENTS AND ACTIONS, 1984, 15 (3-4) :216-228
[5]   DEFINITION AND ANTAGONISM OF HISTAMINE H2-RECEPTORS [J].
BLACK, JW ;
PARSONS, EM ;
DURANT, CJ ;
DUNCAN, WAM ;
GANELLIN, CR .
NATURE, 1972, 236 (5347) :385-&
[6]   SYNTHESIS AND ADRENOCORTICAL INHIBITING ACTIVITY OF SUBSTITUTED DIPHENYLALKYLAMINES [J].
BLANK, B ;
ZUCCARELLO, WA ;
COHEN, SR ;
FRISHMUTH, GJ ;
SCARICACIOTTOLI, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1969, 12 (02) :271-+
[7]  
BOYLE F, 1984, Patent No. 122693
[8]   THE LEUCKART REACTION WITH BETA-PHENYL KETONES [J].
BURCKHALTER, JH ;
JOHNSON, SH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1951, 73 (10) :4830-4832
[9]  
BUSCHAUER A, 1991, AGENT ACTION SUPPL, V33, P231
[10]  
BUSCHAUER A, 1991, PHARMAZIE, V46, P840